Analysis of the epidemiological situation on COVID-19: a second wave
https://doi.org/10.25789/YMJ.2021.73.17
Abstract
The analysis of prevalence, morbidity, mortality and lethality from COVID-19 for the period from September 1, 2020 to January 4, 2021 was carried out. According to the data obtained, during the analyzed period (18 weeks), the prevalence and incidence rates of new coronavirus infection increased significantly. The highest prevalence of COVID-19 has been registered in the USA, Spain, France. The lowest prevalence and incidence rates for new coronavirus infection have been revealed in China and Thailand.
Keywords
About the Authors
T. E. Popova
Scientific center of complex med. Problems
Russian Federation
Russian Federation
Popova Tatyana Egorovna - Doctor of Medical Sciences, deputy director
Yakutsk
O. G. Tikhonova
Scientific center of complex med. Problems
Russian Federation
Russian Federation
Tikhonova Olga G - Scientific secretary
Yakutsk
A. N. Romanova
Scientific center of complex med. Problems
Russian Federation
Russian Federation
Romanova Anna Nikolaevna - Doctor of Medical Sciences, director
Yakutsk
A. A. Tappakhov
Medical Institute of M.K. Ammosov Northeastern Federal University;
Clinics of M.K. Ammosov NEFU;
YSC CMP
Russian Federation
Russian Federation
Tappakhov Aleksey Alekseevich - candidate of medical sciences, associate professor;
senior researcher, ESL of neuropsychophysiological researches;
senior researcher, the Center for neurodegenerative diseases
M. E. Andreev
NEFU;
YSC CMP
Russian Federation
Russian Federation
Andreev Michil Egorovich - research assistant ESL Clinics;
senior researcher
References
1. Analysis of the epidemiological situation for COVID-19 / T.E. Popova, O.G. Tikhonova, A.N. Romanova [et al.] // Yakut Medical Journal. – 2020. – 3 (71). – С. 63-37. (in Russ). DOI 10.25789/YMJ.2020.71.17
2. Ali I. COVID-19: Are We Ready for the Second Wave? / I. Ali // Disaster Med. Public. Health Prep. – 2020. –14(5). – Р. e16-e18. DOI: 10.1017/dmp.2020.149.
3. A novel coronavirus from patients with pneumonia in China, 2019 / N. Zhu, D. Zhang, W. Wang [et al.]. // N. Engl. J. Med. – 2020. – 382. – Р. 727-733. DOI: 10.1056/NEJMoa2001017.
4. A novel coronavirus outbreak of global health concern / C. Wang, P.W. Horby, F.G. Hayden, G.F. Gao // Lancet. – 2020. – 395 (10223). – Р. 470-473. DOI: https://doi.org/10.1016/S0140-6736(20)30185-9.
5. A Review of the Progress and Challenges of Developing a Vaccine for COVID-19 / O. Sharma, A.A. Sultan, H. Ding, C.R. Triggle // Front. Immunol. – 2020. –11. – Р.585354. DOI: 10.3389/fimmu.2020.585354.
6. Cacciapaglia G, Cot C, Sannino F. Second wave COVID-19 pandemics in Europe: a temporal playbook / G. Cacciapaglia, C. Cot, F. Sannino // Sci. Rep. – 2020. – 10(1). – Р. 15514. DOI: 10.1038/s41598-020-72611-5.
7. Determining the optimal strategy for reopening schools, the impact of test and trace interventions, and the risk of occurrence of a second COVID-19 epidemic wave in the UK: a modelling study / J. Panovska-Griffiths, C.C. Kerr, R.M. Stuart [et al.] // Lancet Child. Adolesc. Health. – 2020. – 4(11). – Р. 817-827. DOI: 10.1016/S2352-4642(20)30250-9.
8. First-wave COVID-19 transmissibility and severity in China outside Hubei after control measures, and second-wave scenario planning: a modelling impact assessment / K. Leung, J.T. Wu, D. Liu, G.M. Leung // Lancet. – 2020. – 395(10233). Р.1382-1393. DOI: 10.1016/S0140-6736(20)30746-7. Epub 2020 Apr 8.PMID: 32277878
9. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding / R. Lu, X. Zhao, J.Li [et al.] // The Lancet. – 2020. – 395. – Р. 565–74. DOI: https://doi.org/10.1016/S0140-6736(20)30251-8.
10. Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia Denis / Y. Logunov, I. V. Dolzhikova, O.V. Zubkova [et al.] // The Lancet. – 2020. – 396 (10255). – P887-897. DOI:https://doi.org/10.1016/S0140-6736(20)31866-3
11. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem. / P. Conti, A. Caraffa, C.E. Gallenga [et al.] // Biol. Regul. Homeost. Agents. – 2020. –35(1). doi: 10.23812/21-3-E.
12. The Evolution of Covid-19 in Italy after the Spring of 2020: An Unpredicted Summer Respite Followed by a Second Wave / G. De Natale, L. De Natale, C. Troise [et al.] // Int J. Environ. Res. Public. Health. – 2020 – 17(23. – Р. 8708. DOI: 10.3390/ijerph17238708.
13. 1,000,000 cases of COVID-19 outside of China: The date predicted by a simple heuristic / W.W. Koczkodaj , M.A. Mansournia , W. Pedrycz [et al.] // Glob Epidemiol. – 2020. – 23. – Р. 100023. DOI: 10.1016/j.gloepi.2020.100023
14. Wang L., Yan B., Boasson V. A national fight against COVID-19: lessons and experiences from China / L.Wang, B. Yan, V. Boasson // Aust. N. Z. J. Public. Health. – 2020. – 44(6). – Р. 502–507. https://doi.org/10.1111/1753-6405.13042
15. https://covid19.who.int/region/amro/country/us
16. https://covid19.who.int/region/euro/country/it
17. https://covid19.who.int/region/wpro/country/cn
18. https://ncov.blog/countries/us/
19. https://planetcalc.ru/8657/
20. https://www.poisknews.ru/koronavirus/proczent-smertnosti-ot-koronavirusa-po-stranam-s-grafikami/
21. https://news.mail.ru/coronavirus/stat/world/
22. https://www.worldometers.info/coronavirus/country/italy/
23. https://zona.media/coronagraph
Review
For citations:
Popova T.E., Tikhonova O.G., Romanova A.N., Tappakhov A.A., Andreev M.E. Analysis of the epidemiological situation on COVID-19: a second wave. Yakut Medical Journal. 2021;(1):61-64. https://doi.org/10.25789/YMJ.2021.73.17
Views:
22
Email this article 